| Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma (NCT02101905) | National Cancer Institute (NCI) | 2016-11-07 |
| NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse (NCT02348255) | University of California, Davis | 2016-01-01 |
| Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma (NCT01817751) | Virginia Commonwealth University | 2013-04-11 |
| Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme (NCT01648348) | National Cancer Institute (NCI) | 2012-11-01 |
| High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma (NCT01378481) | National Cancer Institute (NCI) | 2012-06-01 |
| Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors (NCT01522820) | Roswell Park Cancer Institute | 2012-03-01 |
| Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases (NCT02967380) | University of Southern California | 2011-12-14 |
| Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors (NCT01131234) | National Cancer Institute (NCI) | 2010-05-01 |
| Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma (NCT00979862) | National Cancer Institute (NCI) | 2010-03-01 |
| Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma (NCT01051557) | National Cancer Institute (NCI) | 2010-01-27 |
| Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme (NCT01122888) | National Cancer Institute (NCI) | 2009-12-01 |
| Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma (NCT00823797) | University of Washington | 2008-10-01 |
| Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma (NCT00423735) | National Cancer Institute (NCI) | 2007-01-24 |
| Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma (NCT00329719) | National Cancer Institute (NCI) | 2006-03-24 |
| Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas (NCT00268385) | National Cancer Institute (NCI) | 2005-12-16 |
| Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor (NCT00049127) | Alliance for Clinical Trials in Oncology | 2003-06-01 |